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*Author for correspondence at address 2E-cadherin is a Ca2+-dependent cell-cell adhesion molecule,
which is mainly expressed in epithelial cells. Recent studies
have shown that E-cadherin has an important role as an
invasion suppressor molecule in epithelial tumor cells.
Syndecan-1 is a cell surface proteoglycan that has been
implicated in a number of cellular functions including cell-
cell adhesion, cell-matrix anchorage and growth factor pre-
sentation for signalling receptors. Its suppression has also
been shown to be associated with malignant transforma-
tion of epithelial cells. In order to better understand the
coordinated regulation of cell-cell and cell-matrix interac-
tions during malignant transformation, we have studied the
expression of syndecan-1 in malignant mammary tumor
cells genetically manipulated for E-cadherin expression. In
invasive NM-e-ras-MAC1 cells, where E-cadherin was
partially downregulated by specific antisense RNA,
syndecan-1 expression was suppressed. Furthermore,
transfection of E-cadherin cDNA into invasive NM-f-ras-
TD cells resulted in the upregulation of syndecan-1
expression in association with decreased invasiveness. In
both cases, regulation of syndecan-1 occurred post-tran-
scriptionally, since syndecan-1 mRNA levels remained
unchanged. Instead, a translational regulation is suggested,
since syndecan-1 core protein synthesis was E-cadherin
dependent. Another cell adhesion protein, b 1-integrin was
not affected by E-cadherin expression. The data provide an
example of coordinated changes in the expression of two
cell adhesion molecules, syndecan-1 and E-cadherin during
epithelial cell transformation.
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SUMMARYINTRODUCTION
Invasion of tissues by tumor cells requires that cells dissociate
from the initial tumor, adhere to the extracellular matrix of
basement membrane, and secrete specific proteolytic enzymes
that can degrade the matrix. Eventually, the invasive cells may
migrate to distant organs to form metastases (Liotta et al.,
1986; Mareel et al., 1991b). The acquisition of an invasive and
metastatic phenotype seems to be dependent on activation or
suppression of molecules associated with cell adhesion. One
example of such molecules is E-cadherin, which is a calcium
dependent cell-cell adhesion molecule that mediates
homophilic binding between epithelial cells (Takeichi, 1990,
1991, 1993). E-cadherin belongs to a family of more than 20
different members. The classical E-, P-, and N-cadherin
represent a subfamily of glycoproteins defined by a common
basic structure. They consist of an extracellular domain con-
taining four major repeats, a single transmembrane domain,
and a highly conserved cytoplasmic domain. The latter
interacts with a and b catenins, plakoglobin, and p120, which
in turn appear to interact with the cytoskeleton (Nagafuchi and
Takeichi, 1989; Ozawa et al., 1989; McCrea et al., 1991;Reynolds et al., 1994; Shibamoto et al., 1995). Interaction of
cadherins with these cytoplasmic proteins is essential for their
cell binding function since any defective interactions between
these molecules appear to pertub cell-cell adhesion (Nagafuchi
and Takeichi, 1988; Ozawa et al., 1989; Oyama et al., 1994;
Kawanishi et al., 1995).
It has become increasingly apparent that an impaired
function of E-cadherin is associated with the development of
the invasive phenotype. In tissue culture conditions reduced
expression of E-cadherin has been shown to correlate with the
invasive phenotype of cancer cells (Behrens et al., 1989; Frixen
et al., 1991; Oda et al., 1994). Furthermore, the invasiveness
has been reduced or abrogated by exogeneous expression of E-
cadherin in various epithelial tumor cells (Frixen et al., 1991;
Vleminckx et al., 1991). Alternatively, down-regulation of E-
cadherin expression by specific antisense RNA has been shown
to render invasiveness to epithelial tumor cells of mouse
mammary gland origin (Vleminckx et al., 1991). In some
invasive tumor cells, which still express E-cadherin, an
adequate interaction with catenins may be perturbed (Mat-
suyoshi et al., 1992; Shimoyama et al., 1992; Morton et al.,
1993; Kawanishi et al., 1995). The discovery of E-cadherin
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evidence that alterations in E-cadherin play a major role in the
development of invasive cancer (Becker et al., 1994; Oda et
al., 1994). 
The adhesive interactions of the cells with the extracellu-
lar matrix are also modified during malignant transforma-
tion. The syndecans, which are cell surface heparan and
chondroitin sulfate proteoglycans, comprise a family of
adhesion molecules that participate in cell-matrix interac-
tions (Bernfield et al., 1992; Elenius and Jalkanen, 1994).
They consist of a large distinct ectodomain containing
attachment sites for glycosaminoglycans, besides highly
conserved transmembrane and cytoplasmic domains.
Syndecan-1 is a well characterized member of this protein
family. It can selectively bind matrix molecules via its gly-
cosaminoglycan side chains (Koda et al., 1985; Saunders and
Bernfield, 1988; Sun et al., 1989; Salmivirta et al., 1991,
1992b, 1994), and simultaneously interact with heparin
binding growth factor FGF-2 (Salmivirta et al., 1992a). In
spite of a colocalization of syndecan-1 with actin filaments
in epithelial cells (Rapraeger et al., 1986), the cytoplasmic
domain of syndecan-1 does not directly mediate the interac-
tion with the cytoskeleton (Miettinen and Jalkanen, 1994).
However, the cytoplasmic domain is needed for a proper
targeting of syndecan-1 onto basolateral surfaces of epi-
thelial cells (Miettinen et al., 1994).
Syndecan-1 expression is suppressed in malignant transfor-
mation of mammary epithelial cells induced by steroid (Leppä
et al., 1991) or Ha-ras oncogene (Kirjavainen et al., 1993) as
well as in chemically transformed keratinocytes (Inki et al.,
1992a). Transfection of syndecan-1 cDNA into mouse
mammary epithelial tumor cells restores the epithelioid
phenotype, and inhibits malignant growth (Leppä et al., 1992;
Mali et al., 1994), whereas the loss of syndecan-1 by the
expression of antisense RNA causes a fusiform morphology
and anchorage-independent growth (Kato et al., 1995). These
results suggest that syndecan-1 is required in the stabilization
of epithelioid morphology. In addition, expression of
syndecan-1 in both epithelioid and B-lymphoid cells inhibits
their invasion into type I collagen (Kato et al., 1995; Liebers-
bach and Sanderson, 1994). In immunohistochemical studies,
syndecan-1 suppression has also been associated with
malignant phenotype and poor differentiation of mouse skin
tumors induced by UV-irradiation (Inki et al., 1991), in carci-
nomas produced from transformed mouse keratinocytes in
nude mice (Inki et al., 1992b) and in human squamous cell car-
cinomas (Inki et al., 1994a,b,c).
Deregulation of syndecan-1 expression in malignant trans-
formation is still poorly understood. Some tumor cells can
post-translationally modify syndecan-1 expression by altering
its glycosylation (Inki et al., 1992a). Regulation of syndecan-
1 expression also appears to involve post-transcriptional sup-
pression (Kirjavainen et al., 1993; Yeaman and Rapraeger,
1993; Sneed et al., 1994), which may provide a notable
mechanism to control the expression of this molecule. In this
study we have investigated syndecan-1 expression in epithelial
tumor cells genetically manipulated by E-cadherin. We show
that localization and expression levels of syndecan-1 mimic
that of E-cadherin. The findings indicate that a reduction of E-
cadherin and syndecan-1 expression occurs in a coordinated
manner during tumor cell invasion.MATERIALS AND METHODS
Cell culture
Normal murine mammary gland (NMuMG) cells (Owens et al., 1974)
and their derivatives were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum (FBS) and
10 m g/ml insulin. Transfections of the E-cadherin cDNAs in sense and
anti-sense orientations were performed by Vleminckx et al. (1991).
NM-e-ras-G1 and NM-e-ras-MAC-1 cells are derived from NM-e
cells that have been transfected with c-Ha-ras and then with either
plasmid pMSG expressing Ecogpt only, or plasmid pMSG-MAC1
expressing Ecogpt and E-cadherin specific antisense RNA, respec-
tively. NM-f-ras-TD-G1 and NM-f-ras-TD-CAM5 cells are derived
from NM-f-ras-TD1 cells that have been cotransfected with plasmid
pSV2gtp expressing Ecogpt and either high molecular weight DNA
of NMuMG cells or plasmid pBATEM2 expressing mouse E-cadherin
cDNA, respectively. The accumulation of newly synthesized
syndecan-1 core protein in cells was induced by a pretreatment of 6
m g/ml brefeldin A (BFA; Sigma) in culture medium for 6 hours. 
Immunofluorescence staining
Cells were grown on glass coverlips to semiconfluence and then fixed
with 3% paraformaldehyde (PFA) or with ice-cold methanol. Prior to
E-cadherin staining, PFA-fixed cells were permeabilized with 0.5%
Triton X-100 in phosphate buffered saline (PBS, pH 7.4). Cells were
washed and blocked with 1% bovine serum albumin (BSA) in PBS.
Incubations with primary antibody were done at room temperature
(RT) for 1 hour using syndecan-1-specific monoclonal antibody
(mAb) 281-2 (30 m g/ml) (Jalkanen et al., 1985), E-cadherin-specific
mAb DECMA-1 (1:200 dilution; Sigma), or R322 rabbit antiserum
against b 1-integrin subunit (1:50 dilution) (Heino et al., 1989) in PBS
supplemented with 1% BSA. After several washes bound antibodies
were detected using FITC-conjugated anti-rat IgG (1:40 dilution) or
FITC-conjugated anti-rabbit IgG (1:40 dilution) in PBS and 1% BSA
for 1 hour at RT. Cells were further washed extensively and mounted
using Glysergel (Dako, Glostrup, Denmark).
Flow cytometry
Monolayer cells were washed with ice-cold PBS, detached with 0.5
mM EDTA, resuspended in PBS and centrifuged. Cells were then
incubated with mAb 281-2 or mAb DECMA-1 in 1% BSA-PBS at
4°C for 30 minutes, washed with PBS, and resuspended in 1% BSA-
PBS containing FITC-conjugated anti-rat IgG. After another 30
minute incubation at 4°C, the cells were washed and fixed with 1%
PFA in PBS. Analyses were done using quantitative FACStarPLUS
cytometer (Becton Dickinson, Mountain View, CA).
Northern blotting
Total RNA was isolated from semiconfluent cells by guanidine isoth-
iocyanate extraction and cesium chloride gradient centrifugation as
described (Chirgwin et al., 1979). RNA samples were fractionated by
electrophoresis in a 1% agarose formaldehyde gel and transferred to
Zeta probe membrane (Bio-Rad). The membrane was hybridized to
the multi-prime labeled insert of PM-4 cDNA for mouse syndecan-1
(Saunders et al., 1989) and to rat glyceraldehyde 3-phosphate dehy-
drogenase cDNA (GAPDH) (Fort et al., 1985). pI-19 cDNA for
mouse 28 S ribosomal RNA (Arnheim, 1979) was used as a reference
probe. Quantitations were performed with image analyser system
(Microcomputer Imaging Device version M4; Imaging Research
Inc.).
Quantitation of syndecan-1 on cell surfaces and in culture
medium
For quantitation of syndecan-1, cells were cultured for 3 days and
fresh medium was added 24 hours prior to ectodomain isolation. To
detect syndecan-1 shed from the cell surfaces, conditioned medium
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were washed once with cold PBS, detached by 0.5 mM EDTA-PBS,
and washed again. Cells were then suspended in EDTA-PBS and
treated with 20 m g/ml of trypsin (Sigma) for 10 minutes on ice. After
incubation 100 m g/ml of trypsin inhibitor (Sigma) and 1mM phenyl-
methylsulfonyl fluoride (PMSF; Sigma) were added and cells were
centrifuged. Supernatant was recovered for ectodomain quantitation
and cells were suspended in Isoton for cell counting with a Coulter
Counter (Coulter Electronics, Harpenden, UK).
Supernatants from 1· 105 cells and equal amounts of conditioned
medium were loaded onto a cationic nylon membrane (Zeta-Probe,
Bio-Rad) in a minifold-slot apparatus (Schleicher & Schuell). Non-
specific binding was blocked with 5% non fat dry milk in PBS for 30
minutes at RT. The membrane was then incubated overnight at 4°C
with radioiodinated mAb 281-2 (10,000 cpm/ml) in blocking buffer.
After washes with PBS the bound antibody was visualized by auto-
radiography and quantitated by image analyser.
Western blotting
BFA-treated cells were washed with PBS, and syndecan-1
ectodomain was released by trypsin. Trypsin inhibitor was added to
500 m g/ml and PMSF to 1 mM. Cells were centrifuged, washed with
PBS and lysed with 0.5% Triton-X-100 in immunoprecipitation buffer
at 4°C. For comparison of different samples, lysates containing equal
amounts of proteins and corresponding trypsin-releasable materials
were precipitated with 3 vols ethanol and fractionated by elec-
trophoresis using a 7.5% homogenous polyacrylamide gel (SDS-
PAGE) (Laemmli, 1970). After electrophoresis, samples were elec-
troblotted onto Hybond-N+ nylon membranes (Amersham).
Membranes were blocked with 10% non fat dry milk and 0.4 %
Tween-20 in PBS and probed for syndecan-1 overnight at 4oC with
monoclonal antibody 281-2 (2.5 m g/ml) in PBS containing 0.4%
Tween-20. Membranes were washed four times with PBS containing
0.4% Tween-20, and then further incubated with HRP-conjugated
goat anti-rat IgG (1:5000) in 0.4% Tween-20-PBS for 1 hour at RT.
After washing as above, antigens were visualized using an enhanced
chemiluminence kit (Amersham) and exposure at RT.
Immunoprecipitations
For immunoprecipitations cells were labeled from 6 hours to
overnight with 50 m Ci/ml [35S]-methionine (Trans35S-label, ICN) in
methionine-free DMEM supplemented with 5% dialyzed FBS.
Labeled cells were washed with immunoprecipitation buffer (150 mM
NaCl, 1 mM MgCl2, 1 mM CaCl2, 25 mM Tris-HCl, pH 7.4) scraped
or trypsinized from the culture dishes, washed and lysed in immuno-
precipitation buffer containing 100 mM octylglycoside. DetergentTable 1. Expression of mutated p21ras, E-cadherin and synd
phenot
Cell line Description
NMuMG Mouse mammary epithelial cell line
NM-e Subclone from NMuMG cells
NM-e-ras NM-e cells transfected with c-Ha-ras
NM-e-ras-G1 NM-e-ras cells transfected with control plasmid 
NM-e-ras-MAC1 NM-e-ras cells expressing E-cadherin-specific anti-sense
NM-f Subclone from NMuMG cells
NM-f-ras-TD1 NM-f cells transfected with DNA from T24 cell line,
followed by s.c. injection into nu/nu mice
NM-f-ras-TD-G1 NM-f-ras-TD1 cells transfected with control plasmid
NM-f-ras-TD-CAM5 NM-f-ras-TD1 cells expressing E-cadherin cDNA
Cells were surface-stained for immunofluorescence. Intensity of stainings was s
moderate; ++, strong. Invasiveness was formerly determined in vitro with embryo
+, positive (Vleminckx et al., 1991).soluble fractions were preabsorbed by incubation with protein-A-
Sepharose beads (Pharmacia, Sweden) for 2 hours and after removing
the beads, the solution was mixed with mAb DECMA-1 for E-
cadherin or with R322 antiserum for b 1-integrins, and incubated for
12 hours at 4°C. Immunocomplexes were collected using rabbit anti-
rat IgG (for mAb DECMA-1) and Protein-A-Sepharose beads for 2
hours at 4°C, washed 4 times with immunoprecipitation buffer con-
taining 0.1% BSA and 0.1% Triton-X-100 and twice with immuno-
precipitation buffer, alone. The beads were collected by centrifuga-
tion, suspended in sample buffer and boiled. Samples were analyzed
in a 6% homogenous SDS-PAGE (Laemmli, 1970). After elec-
trophoresis the gels were subjected to fluorography using the PPO
enhancing system.
RESULTS
Expression of E-cadherin in mammary epithelial
tumor cells
To investigate the coordinated regulation of cell-cell and cell-
matrix interactions during malignant transformation we used
eight murine mammary tumor variants that have been used to
demonstrate invasion suppression activity of E-cadherin. The
cells are derived from the NMuMG cell line, which is an
uncloned heterogeneous cell population (Owens et al., 1974).
Variants exhibit growth and phenotypic diversities due to sub-
cloning and genetic manipulation with c-Ha-ras oncogene and
E-cadherin cDNA, and can be divided into two subfamilies
according to their epithelioid (NM-e) and fibroblastic (NM-f)
stem cell clones (Table 1). The distribution of E-cadherin was
examined by immunofluorescence microscopy using a mAb
DECMA-1 (Fig. 1). As shown by Vleminckx et al. (1991),
NM-e-derived cells were found to express E-cadherin, which
was concentrated at their intercellular boundaries. These cells
include NM-e cell clone (Fig. 1A), parental NM-e-ras (Fig.
1B), and control-transfected NM-e-ras-G1 cell lines (Fig. 1C).
However, NM-e-ras-MAC-1 cells (Fig. 1D) expressing E-
cadherin-specific antisense RNA showed a fibroblastic mor-
phology and less intense E-cadherin staining as compared with
other NM-e-derived cells. 
Ras-transformed derivatives of NM-f cells were obtained by
transfection of cells with genomic DNA from human tumor
cell line T24. Such cells were injected subcutaneously intoecan-1 in mammary epithelial cells with different  invasive
ypes
Phenotype
Mutated p21ras E-cadherin Syndecan-1 Invasiveness
- + ++ -
- + ++ -
+ + ++ -
+ + ++ -
 RNA + +/- +/- +
- -/ + - -
+ - - +
+ - - +
+ + + -
cored as follows: -, negative; -/ +, weak; +/-, partial downregulation; +,
nic chick heart or collagen matrix as a target; scores are as follows; - , negative;
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Fig. 1. Immunostaining of E-
cadherin in NM cells. Cells
were fixed with 3.0 % PFA and
permeabilized with 0.5 %
Triton-X-100. E-Cadherin was
localized at the intercellular
boundaries of epithelial-like
cells by using a monoclonal
antibody DECMA-1. Cell lines:
(A) NM-e; (B) NM-e-ras; (C)
NM-e-ras-G1; (D) NM-e-ras-
MAC1; (E) NM-f; (F) NM-f-
ras-TD1; G. NM-f-ras-TD-G1,
H. NM-f-ras-TD-CAM5. Bar,
25 m m.athymic nude mice. NM-f-ras-TD1 is the established cell line
that was isolated from the resulting malignant tumors. From
NM-f-derivative stem cells (Fig. 1E), parental NM-f-ras-TD1
(Fig. 1F), and control transfected NM-f-ras-TD-G1 cells (Fig.
1G) expressed fibroblastic morphology and showed diffuse E-
cadherin staining that was not detectable at the sites of cell-
cell contacts. On the contrary, in NM-f-ras-TD-CAM5 trans-Fig. 2. Immunostaining of syndecan-1 in
NM cells. Cells were fixed with 3.0 %
PFA and syndecan-1 was localized on the
cell surfaces of epithelial-like cells by
using a monoclonal antibody 281-2. Cell
lines: A. NM-e; B. NM-e-ras; C. NM-e-
ras-G1; D. NM-e-ras-MAC1; E. NM-f;
F. NM-f-ras-TD1; G. NM-f-ras-TD-G1,
H. NM-f-ras-TD-CAM5; I. NM-e-ras,
negative control; stained only with FITC-
conjugated anti-rat IgG. Bar, 25 m m.fectants expressing exogenous E-cadherin (Fig. 1H), staining
was localized mostly at the cell-cell contact areas.
Expression of syndecan-1 in epithelial tumor cells is
controlled by E-cadherin
The localization of syndecan-1 on cell surfaces was then
analyzed by using mAb 281-2 (Fig. 2). Similar to E-cadherin
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A
B
Fig. 3. FACS analysis of syndecan-1 and E-cadherin in NM-cells.
Cells were stained in suspension with mAb 281-2 or mAb DECMA-
1, fixed with 1% PFA and analyzed by FACS.staining, syndecan-1 was strongly expressed in three epithelioid
cell lines including NM-e cells (Fig. 2A), parental NM-e-ras
(Fig. 2B) and control transfectant NM-e-ras-G1 (Fig. 2C). The
staining was localized on the membranes particularly at the areas
of cell-cell contacts. Instead, on NM-e-ras-MAC1 cells a clear
downregulation of syndecan-1 expression was detected (Fig.
2D). All NM-f-derived cells (Fig. 2E-G) except E-cadherin-
expressing transfectant NM-f-ras-TD-CAM5 (Fig. 2H) were
negative for syndecan-1 staining. NM-f-ras-TD-CAM5 cells
(Fig. 2H) showed positive syndecan-1 expression at their cell
surfaces that was not observed with control stainings (Fig. 2I). 
The expression levels of E-cadherin and syndecan-1 were
further compared using FACS analysis (Fig. 3). Both parental
NM-e-ras and control transfected NM-e-ras-G1 cells
expressed high amounts of syndecan-1 and E-cadherin at their
cell surfaces. However, in NM-e-ras-MAC1 cells, which show
a twofold reduction in E-cadherin expression, syndecan-1 was
also suppressed (Fig. 3A). With regard to NM-f-derived cells,
syndecan-1 expression was also positively correlated with E-
cadherin (Fig. 3B). Syndecan-1 expression was unchanged or
slightly reduced in control-transfected NM-f-ras-TD-G1 cells
as compared to parental NM-f-ras-TD1 cells. Similarly, E-
cadherin was detected at low levels. Instead, a majority of E-
cadherin-transfected cells were shown to express high levels
of syndecan-1 and intermediate levels of E-cadherin.
Syndecan-1 mRNA levels do not follow E-cadherin
expression
To test whether the changes in syndecan-1 expression correlate
with mRNA levels total RNAs were analyzed by northern
blotting. Hybridization with a cDNA probe for syndecan-1
revealed a decrease in the amount of syndecan-1 mRNA in
NM-f-derived cells as compared to NM-e-derived ones (Fig.
4), suggesting that the suppression of syndecan-1 mRNAs in
NM-f cells occurs at the level of transcription. However, the
analysis of the levels of syndecan-1 mRNAs in E-cadherin
manipulated cell lines showed that there was in fact no corre-
lation between the levels of syndecan-1 mRNAs and the levels
of E-cadherin or syndecan-1 proteins detected by immunoflu-
orescence and FACS analysis. NM-e-ras-MAC1 cells accu-
mulated syndecan-1 mRNA as much as other NM-e derived
cells. Furthermore, syndecan-1 mRNA was not upregulated in
E-cadherin-expressing NM-f-ras-TD-CAM5 cells if compared
to other NM-f-derived cells (Fig. 4A). Quantitation by
scanning and blotting the results against 28 S ribosomal RNA
confirmed that E-cadherin expression does not affect the accu-
mulation of syndecan-1 mRNAs (Fig. 4B).
Syndecan-1 suppression is not due to increased
proteolytic cleavage of the ectodomain
One possible mechanism for the regulation of syndecan-1
expression is the proteolytic cleavage of syndecan-1 from the
cell surface into culture medium (Jalkanen et al., 1987).
Therefore, we measured shedding of syndecan-1 into the
culture medium. Conditioned media were collected from the
same cells, which were further analyzed for their syndecan-1
quantity by an established slot blot assay (Jalkanen et al.,
1987). The quantitation of syndecan-1 from the cell surfaces
agreed well with the immunofluoresence stainings (Fig. 5A and
B). All cell lines were found to express detectable levels of
syndecan-1, but the expression levels were approximately 5times lower in NM-f-derived than in NM-e-derived cells (data
not shown). Analysis of syndecan-1 from culture medium also
revealed that suppression of syndecan-1 in NM-e-ras-MAC1-
cells was not due to increased proteolytic cleavage of the
ectodomain (Fig. 5C). On the contrary, upregulation of
syndecan-1 in NM-f-ras-TD-CAM5 cells was not due to
decreased shedding into the culture medium but rather
followed the expression onto the cell surfaces (Fig. 5D). When
the total syndecan-1 expression was estimated by adding the
relative amounts of the cell surface syndecan-1 to the amounts
shed into the culture medium, a clear down-regulation of
syndecan-1 protein was observed in NM-e-ras-MAC1 cells
(data not shown). On the contrary, total syndecan-1 amounts
were markedly increased in NM-f-ras-TD-CAM5 as compared
to parental and control transfected cells (data not shown).
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Fig. 4. (A) Northern analysis of syndecan-1 mRNA levels in NM
cells. RNA samples of 10 m g were fractioned on a 1% formaldehyde
agarose gel, transferred onto Gene Screen Plus membrane, and
hybridized to 32P-labeled probes for syndecan-1 and GAPDH. The
migration of 18S and 28S ribosomal RNAs is indicated on the right.
(B) Quantitation of syndecan-1 mRNA levels by image analyser. The
values were normalized against 28S ribosomal RNA.
Fig. 5. Quantitation of syndecan-1 from NM-e-ras (A and C) and
NM-f-ras TD1 (B and D) cells and their derivatives. Trypsin-
released ectodomains (A and B) and conditioned medium (C and D)
corresponding to 1· 105 cells were loaded onto a cationic nylon
membrane, and probed for syndecan-1 with a radioiodinated mAb
281-2. Results are presented as % of parental cell lines (mean ± SD)
from triplicate samples.Syndecan-1 core protein synthesis is dependent on
E-cadherin expression
In many cells brefeldin A (BFA) results in a block in protein
transport out of the endoplasmic reticulum to the Golgi and
results in the retention of secretory and membrane proteins in
the endoplasmic reticulum (Klausner et al., 1992). This allows
the analysis of protein translation by visualization of newly
synthesized core proteins in the endoplasmic reticulum.
Recently it has also been shown that in a melanoma cell line
BFA inhibits chondroitin sulfate chain elongation, but it does
not affect protein synthesis (Spiro et al., 1991). Similarly,
heparan sulfate chain elongation could be prevented by BFA
in NMuMG-derived NOG-8 cells (Kirjavainen et al., 1993).
Therefore, control transfected NM-e-ras-G1 cells and NM-e-
ras-MAC1 cells expressing E-cadherin-specific antisense
RNA were treated with 6 m g/ml BFA for 6 hours and thenexamined for the accumulation of syndecan-1 core protein.
Cell surface material was isolated with trypsin and cells were
further extracted with Triton X-100. Both fractions were
analyzed by SDS-PAGE as shown in Fig. 6A. Syndecan-1 core
protein, with an apparent size of 80 kDa, accumulated in
control transfected NM-e-ras-G1 cells during BFA-treatment
(Fig. 6A, lane 1). The typical smear of syndecan-1 was
observed in the trypsin-released fraction of NM-e-ras-G1 cells
(Fig. 6A, lane 2). Interestingly, syndecan-1 core protein from
NM-e-ras-MAC1 cells accumulated notably less than that
from control transfected cells (Fig. 6 A, lane 3). Similar sup-
pression to that shown above (Fig. 3) was also detected in
trypsin-released ectodomains from NM-e-ras-MAC-1 cells
(Fig. 6A, lane 4). The obtained blot was further quantitated by
image analyser, which showed a fivefold difference in the
amount of syndecan-1 core protein between Nm-e-ras-G1 and
NM-e-ras-MAC1 cells (Fig. 6C).
Equally to NM-e derived cell lines, control transfected NM-
f-ras-TD-G1 cells and NM-f-ras-TD-CAM5 cells expressing
E-cadherin cDNA were treated with BFA (Fig. 6B). As
expected from earlier analysis of syndecan-1 expression (Figs
2-5), the levels of synthesized syndecan-1 core proteins were
lower than those from NM-e-derived cells. Therefore, filters
were subjected to a longer exposure. As shown in figure 6B,
syndecan-1 core protein from control transfected NM-f-ras-
TD-G1 cells was hardly detectable (Fig. 6B, lane 1). The
trypsin-released fraction of syndecan-1 appeared as a weak
smear of approximately 250 kDa (Fig. 6B, lane 2). However,
syndecan-1 core protein from NM-f-ras-TD-CAM5 cells accu-
mulated higher amounts than that from the control transfected
cells (Fig. 6B, lane 3). Similar upregulation was noticed in the
trypsin-released fraction of NM-f-ras-TD-CAM5 cells (Fig.
6B, lane 4). Quantitation showed that the increase in the
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Fig. 6. Western blot of newly synthesized syndecan-1 in NM-e-ras-
and NM-f-ras-TD-derived cells. Cells were treated 6 h with BFA,
detached with trypsin, and extracted with 0.5% Triton-X-100. For
each cell line, intracellular (lanes 1 and 3) and cell surface (lanes 2
and 4) fractions were resolved in parallel in 7.5% SDS-PAGE, and
blotted onto Hybond-N+ nylon membrane. Syndecan-1 was detected
with mAb 281-2, followed by HRP-conjugated anti-rat IgG.
(A) Control transfected NM-e-ras-G1 cells (lanes 1 and 2) and NM-
e-ras-MAC1 cells expressing E-cadherin-specific anti-sense RNA
(lanes 3 and 4). (B) Control-transfected NM-f-ras-TD-G1 cells
(lanes 1 and 2) and NM-f-ras-TD-CAM5 cells expressing E-cadherin
cDNA (lanes 3 and 4). Molecular weight markers are indicated on
the right. (C and D) Quantitation of syndecan-1 core protein levels
by image analyser. The results show the mean and range of two
independent experiments.
Fig. 7. Expression of E-cadherin in BFA-treated cells. Cells were
incubated 6 h with BFA and [35S]methionine, detached with trypsin
and immunoprecipitated with mAb DECMA-1. Immunoprecipitated
proteins were analyzed by 6% SDS-PAGE and fluorography.amount of syndecan-1 core protein was approximately 2.5-fold
in NM-f-ras-TD-CAM5 cells as compared to NM-f-ras-TD-
G1 cells (Fig. 6D).
The results were confirmed by immunostaining. Treatment
of NM-cells with BFA resulted in a diffuse intracellular
staining pattern, which resembled reticular staining typical for
the endoplasmic reticulum but some syndecan-1 was still
localized on the cell surface. A decreased accumulation of
syndecan-1 in NM-e-ras-MAC1 cells and an increased accu-
mulation of syndecan-1 in NM-f-ras-TD-CAM5 cells was also
observed with this technique (data not shown). Immunopre-
cipitation analysis revealed that E-cadherin was also intracel-
luarly accumulated in BFA-treated cells with the exception of
NM-f-ras-TD-G1 cells (Fig. 7A and B). E-cadherin was
expressed mostly as a 135 kDa precursor polypeptide but some
120 kDa polypeptide form could also be detected.
To test the possibility that the suppression of syndecan-1
core protein reflects increased degradation in the endoplasmic
reticulum we examined whether syndecan-1 core protein wasdegraded faster in cells expressing low levels of E-cadherin.
Therefore, syndecan-1 core protein was accumulated for 3
hours and then chased for 1, 2 and 3 hours in the presence of
BFA and cycloheximide. As a result we could not detect any
clear differences in syndecan-1 core protein levels during the
chase, and thus conclude that the core protein turnover rate is
not markedly affected in E-cadherin-manipulated cells (data
not shown). 
The expression of b 1-integrin subunit is not
influenced by E-cadherin
To address the specificity of the E-cadherin-dependent
expression of syndecan-1, we examined the expression of
another matrix binding protein, b 1 integrin, in E-cadherin
manipulated NM cell lines. In the presence of divalent cations
R322 antiserum can coprecipitate b 1-related a -subunits (Heino
et al., 1989). As shown in Fig. 8, the expression levels of b 1-
integrin subunits and associated a s were similar in control
transfected NM-e-ras-G1 (Fig. 8A, lane 1) and NM-e-ras-
MAC1 cells (Fig. 8A, lane 2) expressing E-cadherin-specific
antisense RNA. Immunoprecipitation analysis revealed two
major bands of similar size corresponding to a and b 1 subunits
of integrin molecules, respectively. A b 1-precursor of approx-
imately 115 kDa was only faintly visible, suggesting that b 1
chain is processed relatively rapidly. The quantitation showed
a 6% difference in the amount of b 1 subunit between Nm-e-
ras-G1 and NM-e-ras-MAC1 cells. Similar expression levels
and size of b 1-integrins were also observed in control trans-
fected NM-f-ras-TD-G1 (Fig. 8A, lane 3) and E-cadherin-
expressing NM-f-ras-TD-CAM5 cells (Fig. 8A, lane 4). The
increase in the amount of b 1 subunit was 8% in NM-f-ras-TD-
CAM5 cells as compared to NM-f-ras-TD-G1 cells.
The b 1 integrin subunit was further localized by immuno-
fluoresence. In both NM-e-ras-derived (Fig. 8B, panels A and
B) and NM-f-ras-TD1-derived (Fig. 8B, panels C and D) trans-
fectants b 1-integrin is transported to the cell surface but it does
not show a clear concentrations at sites of cell-cell contacts. In
permeabilized cells b 1-integrin shows a perinuclear staining
pattern together with the distribution over the entire cell
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Fig. 8. Expression of b 1-integrins
in NM-e-ras- (lanes 1 and 2) and
NM-f-ras-TD-derived cells (lanes
3 and 4). (A) Cells were
metabolically labeled with
[35S]methionine, harvested and
immunoprecipitated with R322
immunoserum specific for b 1-
integrin subunit. Molecular
weight markers are indicated on
the right. (B) Immunolocalization
of the b 1-integrin subunit in NM-
e-ras- and NM-f-ras-TD-derived
cells. Cells were fixed with 3.0 %
PFA and stained for b 1-integrin
subunit using R322
immunoserum. Cell lines: A. NM-
e-ras-G1; B. NM-e-ras-MAC1;
C. NM-f-ras-TD-G1; D. NM-f-
ras-TD-CAM5. Bar, 25 m m.surface (data not shown). The perinuclear staining presumably
represents b 1-integrins in endoplasmic reticulum and Golgi
apparatus. In conclusion, these results show that b 1-integrin
expression is not dependent on E-cadherin.
DISCUSSION
In the present study we have analyzed syndecan-1 expression
in mouse mammary tumor cells genetically manipulated by E-
cadherin-specific cDNA (Vleminckx et al., 1991). In this
model E-cadherin expression correlates with the epithelioid
phenotype and suppresses the invasive phenotype. Further-
more, downregulation of E-cadherin expression induces a
fusiform phenotype and invasiveness of previously noninva-
sive epithelial cells. It is well established that the adhesive
function of E-cadherin is mediated through the interaction of
E-cadherin with catenins which in turn anchors the cadherin-
complex to the actin filaments (Nagafuchi and Takeichi, 1989;
Ozawa et al., 1989; McCrea et al., 1991; Reynolds et al., 1994;
Shibamoto et al., 1995). Disruption of cell-cell contacts
together with altered expression of other adhesive components
would eventually lead to breakdown of the organized epithe-
lial monolayer. We found that syndecan-1 expression was
dependent on the expression of E-cadherin. Like E-cadherin,
syndecan-1 is a molecule which has been shown to participate
in the stabilization of epithelial cell sheets and cytoskeletal
organization (Leppä et al., 1992; Mali et al., 1994; Kato et al.,
1995). Our results show that E-cadherin and syndecan-1 are
coordinately regulated and may thus act in concert to stabilize
epithelial morphology.
Syndecan-1 from epithelial cells binds strongly to type I
collagen in vitro (Koda et al., 1985). Recently, it was also
shown that a direct interaction of syndecan-1 with type I
collagen prevents B-lymphoid cell invasion (Liebersbach and
Sanderson, 1994), indicating that syndecan-1 expressionindeed can influence cell behavior by its extracellular interac-
tions. In addition, syndecan-1 may also participate in cell-cell
adhesion. Although it is localized on the entire surface of NM-
cells, it is strongly expressed at the intercellular spaces, which
are not predominant expression sites for syndecan-1 ligands.
Support for syndecan-1 participating in cell-cell adhesion can
also be found from histological studies, where syndecan-1 was
localized at lateral surfaces of simple epithelia and at the entire
surface of stratified epithelia (Hayashi et al., 1987). Syndecan-
1 is also expressed at cell-cell contact areas in early mouse
embryos (Sutherland et al., 1991), and in developing kidneys
(Vainio et al., 1992). 
Coordinated expression of E-cadherin and
syndecan-1
Immunohistochemical studies have shown a similar expression
pattern of E-cadherin and syndecan-1 in epithelial tumors. For
example, they are both expressed in well-differentiated
squamous cell carcinomas but are absent in poorly differenti-
ated ones (Schipper et al., 1991; Inki et al., 1994b). E-cadherin
and syndecan-1 are also expressed in well differentiated areas
of epithelial tumors produced in nude mice (Inki et al., 1992b;
Mareel et al., 1991a). Here, we have shown that both the local-
ization and the expression levels of syndecan-1 mimic those of
E-cadherin. The mechanisms that lead to suppression of
syndecan-1 in NM-e-ras-MAC1 cells expressing E-cadherin-
specific antisense RNA and conversely upregulation of
syndecan-1 in E-cadherin expressing NM-f-ras-TD-CAM5
cells are unclear. It seems possible that E-cadherin and
syndecan-1 may share same transport mechanisms, since BFA
also blocked the transport of E-cadherin to the cell surface of
NM-cells. On the other hand, in polarized MDCK cells the
transport of both E-cadherin and syndecan-1, unlike the poly-
Ig receptor, to the basolateral cell surface is not inhibited by
BFA (Low et al., 1992; Apodaca et al., 1993, Miettinen et al.,
1994). It is tempting to speculate that the excess of newly syn-
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be degraded unless E-cadherin is expressed at a certain
threshold level. However, our results are against this hypoth-
esis, since we could not detect any clear differences in the
turnover of syndecan-1 core protein in the endoplasmic
reticulum, whereas the accumulation of syndecan-1 core
protein was affected (Fig. 6). 
Another mechanism could be that E-cadherin expression is
involved in the regulation of a large pattern of cellular proteins,
which together maintain a particular phenotype inducing sup-
pression of malignancy. Evidence for this comes from the
study of McNeill and coworkers (1990), who showed that the
expression of E-cadherin in transfected L fibroblasts lacking
endogenous E-cadherin induces redistribution of the Na+,K+-
ATPase to the sites of cell-cell-contacts. Therefore, E-cadherin
would be a molecule involved in the polarization of epithelial
cells. Syndecan-1 would function as a helper-molecule for E-
cadherin, as it is capable of restoring the epithelial-like mor-
phology in cancer cells (Leppä et al., 1992; Mali et al., 1994;
Kato et al., 1995). It is also possible that a certain threshold
level of syndecan-1 expression in some other cell types may
have a signaling role for organization of a proper cytoskeletal
network. This is supported by the finding that Schwann cells,
which do not express syndecan-1, lack an organized actin
filament network but aquire more prominent stress fibers after
syndecan-1 transfection (Carey et al., 1994).
A post-transcriptional mechanism regulates
syndecan-1 expression in E-cadherin-manipulated
cells
Syndecan-1 mRNA levels were shown to be suppressed in all
NM-f-derived cells, apparently independent of E-cadherin
expression (Fig. 4). The difference in syndecan-1 mRNA levels
between NM-e- and NM-f-derived cells possibly reflects alter-
ations in the transcription rate or in mRNA stability. However,
syndecan-1 core protein accumulation was shown to be E-
cadherin-dependent (Fig. 6). BFA treatment allowed us to
detect syndecan-1 core protein as a sharp band by western
blotting, indicating that glycosylation of the core protein was
prevented in these cells. Recently, it was shown that rat ovarian
granulosa cells synthesize heparan sulfate proteoglycans in the
presence of BFA (Uhlin-Hansen and Yanagishita, 1993).
Together these studies indicate that depending on the cell type
BFA can differentially affect the glysosaminoglycan
elongation.
At the moment we can conclude that syndecan-1 core
protein synthesis is affected by the expression of E-cadherin.
A possible explanation for the reduced accumulation of
syndecan-1 core protein in the presence of BFA is that trans-
lation of syndecan-1 is suppressed. In developing kidney,
syndecan-1 expression appears to be post-transcriptionally
regulated, since uninduced mesenchymal cells store syndecan-
1 mRNA and utilize it only after induction by the metanephric
duct (Vainio et al., 1992). Similarly, syndecan-1 mRNA accu-
mulates in peritoneal macrophages during inflammatory
recruitment, but no syndecan-1 can be detected at protein level
(Yeaman and Rapraeger, 1993). Furthermore, regulation may
be translational also during malignant transformation; in spite
of syndecan-1 mRNA accumulation in Ha-ras-transformed
NOG-8 ras cells, newly synthesized core protein was barely
detectable (Kirjavainen et al., 1993). Our results together withthe previous findings suggest that post-transcriptional block
may be a common process for controlling the expression of
syndecan-1. 
There are other examples of translational control in the reg-
ulation of protein expression. Stable secondary structures
within the 5¢ -untranslated region (5¢ UTR) have been suggested
to inhibit the initiation of translation (Kozak, 1991). For
example, ornithine decarboxylase mRNA, coding for the major
regulatory enzyme in polyamine synthesis, and transforming
growth factor-b 1 (TGF- b 1) mRNA contain a G/C-rich 5¢ UTR,
that has been predicted to form stable stem-loop structures.
These stem-loops were shown to inhibit translation of mRNAs
(Manzella and Blackshear, 1990, Grens and Scheffler, 1990,
Kim et al., 1992). Similarly, the 5¢ UTR of syndecan-1 mRNA
has been predicted to form stable secondary structures
(Saunders et al., 1989). The possibility that the 5¢ UTR of
syndecan-1 mRNA exerts an inhibitory effect on syndecan-1
translation remains to be resolved.
While our study was in preparation, it was reported that
suppression of syndecan-1 by antisense RNA results in down-
regulation of E-cadherin expression in mammary epithelial
cells (Kato et al., 1995). The cells show a phenotype remark-
ably similar to that of cells expressing E-cadherin antisense
RNA. Together these results suggest a coordinated expression
of cell-cell and cell-substrate adhesion molecules during
tumor cell invasion. Identification of the regulatory pathways
used to coordinate the expression of genes participating in the
constitution of the invasive phenotype in cancer will hopefully
help us to understand this disease.
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